Investor news - Demant obtains regulatory approval for the acquisition of KIND.pdf
Kurs
+1,15%
Likviditet
37,5 MDKK
Kalender
| Est. tid* | ||
| 2026-08-11 | 07:50 | Kvartalsrapport 2026-Q2 |
| 2026-03-05 | N/A | Årsstämma |
| 2026-02-03 | 07:30 | Bokslutskommuniké 2025 |
| 2025-08-12 | - | Kvartalsrapport 2025-Q2 |
| 2025-03-07 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2025-03-06 | - | Årsstämma |
| 2025-02-05 | - | Bokslutskommuniké 2024 |
| 2024-08-14 | - | Kvartalsrapport 2024-Q2 |
| 2024-03-07 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2024-03-06 | - | Årsstämma |
| 2024-02-06 | - | Bokslutskommuniké 2023 |
| 2023-08-15 | - | Kvartalsrapport 2023-Q2 |
| 2023-03-09 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2023-03-08 | - | Årsstämma |
| 2023-02-07 | - | Bokslutskommuniké 2022 |
| 2022-08-16 | - | Kvartalsrapport 2022-Q2 |
| 2022-03-11 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2022-03-10 | - | Årsstämma |
| 2022-02-08 | - | Bokslutskommuniké 2021 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-03-08 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2021-03-05 | - | Årsstämma |
| 2021-02-09 | - | Bokslutskommuniké 2020 |
| 2020-08-17 | - | Kvartalsrapport 2020-Q2 |
| 2020-03-11 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2020-03-10 | - | Årsstämma |
| 2020-02-04 | - | Bokslutskommuniké 2019 |
| 2019-08-14 | - | Kvartalsrapport 2019-Q2 |
| 2019-03-20 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2019-03-19 | - | Årsstämma |
| 2019-02-19 | - | Bokslutskommuniké 2018 |
| 2018-08-15 | - | Kvartalsrapport 2018-Q2 |
| 2018-03-23 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2018-03-22 | - | Årsstämma |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-08-14 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-09 | - | Kvartalsrapport 2017-Q1 |
| 2017-03-28 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2017-03-27 | - | Årsstämma |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-11-10 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-25 | - | Split DEMANT 1:5 |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-08 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2016-04-07 | - | Årsstämma |
| 2016-03-01 | - | Bokslutskommuniké 2015 |
| 2015-11-12 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-14 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-07 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-10 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2015-04-09 | - | Årsstämma |
| 2015-02-26 | - | Bokslutskommuniké 2014 |
| 2014-11-13 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-14 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-08 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-10 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2014-04-09 | - | Årsstämma |
| 2014-02-27 | - | Bokslutskommuniké 2013 |
| 2013-11-05 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-14 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-07 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-10 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2013-04-09 | - | Årsstämma |
| 2013-02-26 | - | Bokslutskommuniké 2012 |
| 2012-11-07 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-16 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-10 | - | Kvartalsrapport 2012-Q1 |
| 2012-04-12 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2012-04-11 | - | Årsstämma |
| 2012-02-29 | - | Bokslutskommuniké 2011 |
| 2011-11-10 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-19 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-12 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2011-04-13 | - | Årsstämma |
| 2010-11-16 | - | Kvartalsrapport 2010-Q3 |
| 2010-04-08 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
19.11.2025 12:40:19 CET | Demant A/S | Investor News
Investor news | 19 November 2025 |
Demant obtains regulatory approval for the acquisition of KIND
In June 2025, Demant announced an agreement to acquire KIND Group (KIND), one of the world’s leading retailers of hearing aids with around 650 hearing care clinics. As of today, all regulatory conditions have been fulfilled, which include approvals by both the Austrian and German competition authorities.
With the regulatory conditions now in place, the customary closing conditions remain outstanding, before the parties can close the transaction. This is expected to take place at the beginning of December 2025, at which time we will communicate the financial implications of consolidating KIND into Demant.
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Peter Pudselykke, Head of Investor Relations Gustav Høegh, Investor Relations Officer Henrik Axel Lynge Buchter, Manager of External Communications |
Contacts
- Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 22,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.